Back to top

cell-therapy: Archive

Zacks Equity Research

Waters (WAT) Boosts Waters Operating Segment With HPLC System

Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.

WATNegative Net Change ANegative Net Change TMONegative Net Change BIONegative Net Change

Zacks Equity Research

New Strong Buy Stocks for April 2nd

CXDO, HITI, SIGA, CPG and CTKB have been added to the Zacks Rank #1 (Strong Buy) List on April 2, 2023.

SIGANegative Net Change CPGNegative Net Change CXDONegative Net Change HITINegative Net Change CTKBPositive Net Change

Zacks Equity Research

Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology

Allogene (ALLO) intends to combine its next generation AlloCAR T platform with Arbor Biotechnologies' proprietary CRISPR gene therapy technology to develop therapies for autoimmune diseases.

GSKNegative Net Change ANIPNegative Net Change ADMAPositive Net Change ALLONegative Net Change